Efavirenz requires adequate serum concentrations (1-4 µg/mL) to ensure therapeutic efficacy and avoid central nervous system toxicity. Due to significant interindividual pharmacokinetic variability, therapeutic drug monitoring (TDM) is often necessary. Reliab... ...

请注册登录后继续浏览